Residual viremia is preceding viral blips and persistent low-level viremia in treated HIV-1 patients.
BACKGROUND: It has been suggested that low-level viremia or blips in HIV-infected patients on antiretroviral treatment are related to assay variation and/or increased sensitivity of new commercial assays. The 50-copy cut-off for virologic failure is, therefore, under debate. METHODS: Treated patient...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Public Library of Science (PLoS)
2014-01-01
|
| Serie: | PLoS ONE |
| Accesso online: | http://europepmc.org/articles/PMC4212971?pdf=render |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|